The 340B Program has been a lifeline for providers who care for low-income and vulnerable patients.
Diana DeGette
The Public Record
Diana Louise DeGette is a U.S. Representative for Colorado's 1st congressional district, having served since January 3, 1997. A member of the Democratic Party, she has been a prominent advocate for health care reform and women's rights throughout her tenure in Congress. DeGette has played a significant role in various legislative efforts, particularly in expanding access to health care services. Her work has garnered support from organizations such as the National Association of Community Health Centers.
Thank you very much, and thank you for all of your efforts and your agency's efforts.
I want to ask you about a specific provision of the discussion draft that allows the FDA to include requirements for the packaging of a drug to help protect children from harm, such as through unit-dose packaging or other requirements.
I really want to thank you for going through regular order with this bill, because I think that this is one of those issues that has really been a bugaboo for a long time.
It has been 40 years that we have had this monograph system, but we haven't really made any updates to it.
I support the intent of the program, but I do believe that more transparency and accountability is required.
I think we can stipulate that 340B is critical to provide critical medical services to low-income people.
But we also can stipulate that we need to make sure that our oversight remains robust.
Thanks to this program, providers across the country have been able to purchase discounted pharmaceuticals and expand and improve their services.